Biomarin Pharmaceutical to sell $1.9 billion stock to US investor
Biomarins Pharmaceuticals, a unit of the world’s largest biopharmaceutical company, Takeda Pharmaceutical Co., has been sold to a private equity group, the company said Wednesday.The deal was announced Wednesday in Tokyo.The company, which was founded in 1992, has been working to develop a cancer drug for decades and is also developing the first drug to…